These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 28501716)

  • 1. Cross-protection in Neisseria meningitidis serogroups Y and W polysaccharides: A comparative conformational analysis.
    Kuttel MM; Timol Z; Ravenscroft N
    Carbohydr Res; 2017 Jun; 446-447():40-47. PubMed ID: 28501716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modeling the conformations of Neisseria meningitidis serogroup a CPS and a carba-analogue: Implications for vaccine development.
    Hlozek J; Ravenscroft N; Kuttel MM
    Carbohydr Res; 2019 Dec; 486():107838. PubMed ID: 31654945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epitope specificities of the group Y and W-135 polysaccharides of Neisseria meningitidis.
    Moore SL; Uitz C; Ling CC; Bundle DR; Fusco PC; Michon F
    Clin Vaccine Immunol; 2007 Oct; 14(10):1311-7. PubMed ID: 17804612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative proton nuclear magnetic resonance evaluation and total assignment of the capsular polysaccharide Neisseria meningitidis serogroup X.
    Garrido R; Puyada A; Fernández A; González M; Ramírez U; Cardoso F; Valdés Y; González D; Fernández V; Vérez V; Vélez H
    J Pharm Biomed Anal; 2012 Nov; 70():295-300. PubMed ID: 22877873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunological relationship between the capsular polysaccharides of Neisseria meningitidis serogroups Z and 29E.
    Griffiss JM; Brandt BL
    J Gen Microbiol; 1983 Feb; 129(2):447-52. PubMed ID: 6405009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The capsular polysaccharide of group B Neisseria meningitidis as a vehicle for vaccine development.
    Jennings HJ
    Contrib Microbiol Immunol; 1989; 10():151-65. PubMed ID: 2479499
    [No Abstract]   [Full Text] [Related]  

  • 7. Antigenic determinants driving serogroup-specific antibody response to Neisseria meningitidis C, W, and Y capsular polysaccharides: Insights for rational vaccine design.
    Pietri GP; Bertuzzi S; Karnicar K; Unione L; Lisnic B; Malic S; Miklic K; Novak M; Calloni I; Santini L; Usenik A; Romano MR; Adamo R; Jonjic S; Turk D; Jiménez-Barbero J; Lenac Rovis T
    Carbohydr Polym; 2024 Oct; 341():122349. PubMed ID: 38876728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bacterial polysaccharides as vaccines--immunity and chemical characterization.
    Lee CJ; Lee LH; Lu CS; Wu A
    Adv Exp Med Biol; 2001; 491():453-71. PubMed ID: 14533815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural determination of the polysaccharide antigens of Neisseria meningitidis serogroups Y, W-135, and BO1.
    Bhattacharjee AK; Jennings HJ; Kenny CP; Martin A; Smith IC
    Can J Biochem; 1976 Jan; 54(1):1-8. PubMed ID: 814976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Full 1H NMR assignment and detailed O-acetylation patterns of capsular polysaccharides from Neisseria meningitidis used in vaccine production.
    Lemercinier X; Jones C
    Carbohydr Res; 1996 Dec; 296():83-96. PubMed ID: 9008844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strucutres of the capsular polysaccharides of Neisseria meningitidis as determined by 13C-nuclear magnetic resonance spectroscopy.
    Jennings HJ; Bhattacharjee AK; Bundle DR; Kenny CP; Martin A; Smith IC
    J Infect Dis; 1977 Aug; 136 Suppl():S78-83. PubMed ID: 408435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The immune response to the capsular polysaccharide of Neisseria meningitidis group B.
    Romero JD; Outschoorn IM
    Zentralbl Bakteriol; 1997 Feb; 285(3):331-40. PubMed ID: 9084108
    [No Abstract]   [Full Text] [Related]  

  • 13. Four monoclonal antibodies against capsular polysaccharides of Neisseria meningitidis serogroups A, C, Y and W135: its application in identity tests.
    Reyes F; Amin N; Otero O; Aguilar A; Cuello M; Valdés Y; García LG; Cardoso D; Camacho F
    Biologicals; 2013 Jul; 41(4):275-8. PubMed ID: 23791517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantification of each serogroup polysaccharide of Neisseria meningitidis in A/C/Y/W-135-DT conjugate vaccine by high-performance anion-exchange chromatography-pulsed amperometric detection analysis.
    Gudlavalleti SK; Crawford EN; Harder JD; Reddy JR
    Anal Chem; 2014 Jun; 86(11):5383-90. PubMed ID: 24810004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of four sandwich ELISAs for quantitation of capsular polysaccharides from Neisseria meningitidis serogroups A, C, W and Y in multivalent vaccines.
    Reyes F; Otero O; Cuello M; Amin N; García L; Cardoso D; Camacho F
    J Immunol Methods; 2014 May; 407():58-62. PubMed ID: 24727145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody persistence for up to 5 years after a fourth dose of Haemophilus influenzae type b and Neisseria meningitidis serogroups C and Y-tetanus toxoid conjugate vaccine (HibMenCY-TT) given at 12-15 months of age.
    Marshall GS; Blatter M; Marchant C; Aris E; Mesaros N; Miller JM
    Pediatr Infect Dis J; 2013 Jun; 32(6):662-8. PubMed ID: 23340564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tetravalent meningococcal polysaccharide vaccine groups A, C, Y, W 135: clinical and serological evaluation.
    Armand J; Arminjon F; Mynard MC; Lafaix C
    J Biol Stand; 1982 Oct; 10(4):335-9. PubMed ID: 6818232
    [No Abstract]   [Full Text] [Related]  

  • 18. Conformations of Neisseria meningitidis serogroup A and X polysaccharides: The effects of chain length and O-acetylation.
    Hlozek J; Kuttel MM; Ravenscroft N
    Carbohydr Res; 2018 Jul; 465():44-51. PubMed ID: 29940397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogenicity and side-effects of a new tetravalent meningococcal polysaccharide vaccine.
    Ambrosch F; Wiedermann G; Crooy P; George AM
    Bull World Health Organ; 1983; 61(2):317-23. PubMed ID: 6407768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of O-Acetylation in the Immunogenicity of Bacterial Polysaccharide Vaccines.
    Berti F; De Ricco R; Rappuoli R
    Molecules; 2018 Jun; 23(6):. PubMed ID: 29865239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.